Lymphangioleiomyomatosis — Trials

Lymphangioleiomyomatosis — Trials · CancerIndex

Clinical trials

Registered studies

42 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00414648	Efficacy and Safety of Sirolimus in LAM(MILES)	completed	Phase 3	89	University of CincinnatiOTHER	3	Nov 2, 2023	clinicaltrials
NCT00790400	Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)(EXIST-2)	completed	Phase 3	118	Novartis PharmaceuticalsINDUSTRY	11	Feb 17, 2017